DUBLIN–(BUSINESS WIRE)–The “Transdermal Drug Delivery Devices – Medical Devices Pipeline Assessment, 2020” report has been added to ResearchAndMarkets.com’s offering.
“Transdermal Drug Delivery Devices – Medical Devices Pipeline Assessment, 2020”. Transdermal Drug Delivery Devices is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.
Scope
- Extensive coverage of the Transdermal Drug Delivery Devices under development
- The report reviews details of major pipeline products which includes product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Transdermal Drug Delivery Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Transdermal Drug Delivery Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Key Topics Covered:
1 Tables & Figures
2 Introduction
2.1 Transdermal Drug Delivery Overview
3 Products under Development
3.1 Transdermal Drug Delivery – Pipeline Products by Stage of Development
3.2 Transdermal Drug Delivery – Pipeline Products by Segment
3.3 Transdermal Drug Delivery – Pipeline Products by Territory
3.4 Transdermal Drug Delivery – Pipeline Products by Regulatory Path
3.5 Transdermal Drug Delivery – Pipeline Products by Estimated Approval Date
3.6 Transdermal Drug Delivery – Ongoing Clinical Trials
4 Transdermal Drug Delivery – Pipeline Products under Development by Companies
4.1 Transdermal Drug Delivery Companies – Pipeline Products by Stage of Development
4.2 Transdermal Drug Delivery – Pipeline Products by Stage of Development
5 Transdermal Drug Delivery Companies and Product Overview
6 Transdermal Drug Delivery- Recent Developments 2977 Appendix
7 Appendix
Companies Mentioned
- 3M Co
- 4P Therapeutics LLC
- Actuated Medical Inc
- Adynxx Inc
- Aequus Pharmaceuticals Inc
- Agile Therapeutics Inc
- Allergan Ltd
- AMW GmbH
- AngioSoma Inc
- Apogee Technology Inc
- Asahi Kasei Pharma Corp
- ASCIL Biopharm
- Avecho Biotechnology Ltd
- Avro Life Sciences
- Boryung Pharmaceutical Co Ltd
- Burke Pharmaceuticals LLC
- Candesant Biomedical Inc
- Cassava Sciences Inc
- CB Scientific Inc
- Cerimon Pharmaceuticals, Inc. (Inactive)
- Chrono Therapeutics Inc
- Cipla Ltd
- Clexio Biosciences Ltd
- Corium Inc
- Daewoong Pharmaceutical Co Ltd
- DBV Technologies SA
- DD Therapeutics LLC
- Delpor Inc
- Dermisonics Inc (Inactive)
- Dharma Therapeutics, Inc. (Inactive)
- Diomics Corp
- Drexel University
- DURECT Corp
- Echo Therapeutics Inc
- Emplicure AB
- Endo International Plc
- Extend Biosciences Inc
- Fe3 Medical Inc
- Futura Medical Plc
- Georgia Institute of Technology
- Georgia State University
- Hisamitsu Pharmaceutical Co Inc
- I M Sechenov Moscow State Medical University
- Icure Pharmaceutical Inc
- ImmuPatch
- Indian Institute of Science
- Indian Institute of Technology Bombay
- InMed Pharmaceuticals Inc
- Institute of Materials Research & Engineering
- Intercell AG (Inactive)
- Interstitial NS
- Isis Biopolymer Inc (Inactive)
- Janisys
- KTH Royal Institute of Technology
- Leo Pharma AS
- Livzon Pharmaceutical Group Co Ltd
- Lohmann Therapie-Systeme AG
- Luye Pharma Group Ltd
- Massachusetts Institute of Technology
- Mayne Pharma Group Ltd
- Medherant Ltd
- MEDRx Co Ltd
- MedRx, Inc.
- Microdermics Inc
- Micron Biomedical Inc
- Micropoint Technologies Pte Ltd
- mPhase Technologies Inc
- National University of Singapore
- Nemaura Pharma Ltd
- NeuroDerm Ltd
- Nitto Denko Corp
- North Carolina State University
- Noven Pharmaceuticals Inc
- NutriBand Inc
- Nuvo Pharmaceuticals Inc
- PassPort Technologies Inc
- Privo Technologies Inc
- Prometheon Pharma LLC
- Purdue University
- Quoin Pharmaceuticals Ltd
- Radius Health Inc
- Ryah Medtech Inc
- Samyang Biopharmaceuticals Corp
- Scilex Ltd
- Seelos Therapeutics, Inc.
- Shenox Pharmaceuticals LLC
- Sinsin Pharmaceutical Co Ltd
- SK Chemicals Co Ltd
- Skinject Inc
- Sparsha Pharma International Pvt Ltd
- Sree Chitra Tirunal Institute for Medical Sciences & Technology
- Stanford University
- Starton Therapeutics Inc
- Syntropharma Ltd
- Taho Pharmaceuticals Ltd
- Technology Health Inc
- Teikoku Pharma USA Inc
- tesa Labtec GmbH
- Teva Pharmaceutical Industries Ltd
- Texas Tech University
- The Sheikh Zayed Institute for Pediatric Surgical Innovation
- TheraJect Inc
- Therapeutic Systems Research Laboratories Inc
- TheraSolve NV (Inactive)
- Theratech, Inc.
- Thrudermic LLC
- Titan Pharmaceuticals Inc
- Toa Eiyo Ltd
- Transcu Group Limited (Inactive)
- Transdermal Delivery Solutions Corp
- Transdermal Specialties Inc
- TransPharma Medical Ltd (Inactive)
- Transport Pharmaceuticals Inc
- University of Illinois at Chicago
- University of Toronto
- Vaxess Technologies Inc
- Vaxxas Pty Ltd
- Verndari Inc
- ViiV Healthcare UK Ltd
- Virpax Pharmaceuticals Inc
- Vyteris, Inc. (Inactive)
- Xel Pharmaceuticals Inc
- XPhyto Therapeutic Corp
- Zambon Italia Srl
- Z-Cube Srl
- ZetrOZ Inc
- Zynerba Pharmaceuticals Inc
For more information about this report visit https://www.researchandmarkets.com/r/hkw8cx
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900